Informa (INF) H2 2017 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2017 earnings summary
23 Oct, 2026Executive summary
2017 marked the final year of the four-year Growth Acceleration Plan; revenue and adjusted earnings grew, cash flow strengthened, and dividends increased.
All four divisions delivered underlying revenue growth; strategy remains focused on sustainable growth, scale, and investment in products, platforms, and customer services.
Financial highlights
Reported revenue rose 30.7% to £1.76bn; underlying revenue growth accelerated to 3.4% from 1.6% in 2016.
Adjusted operating profit increased 31.3% to £545m; adjusted diluted EPS rose 9.5% to 46.1p, reflecting trading, expansion, currency and a tax headwind.
Free cash flow reached £400.9m, up ~30% and ahead of the £400m target; reported free cash flow yield was ~7.1%.
The 6% dividend increase brought the dividend to 20.45p per share, covered ~2.25x by earnings.
Outlook and guidance
2018 target: underlying revenue growth north of 3.5%; the outlook envisaged another year of growth, with segment contributions expected to vary.
Exhibitions expected to grow strongly, but at a lower headline rate than in 2017; Academic Publishing and KNN expected to be steady, with BI targeting further progressive growth.
Near-term priority is sustainable revenue growth and reinvestment; accelerating operating profit ahead of revenue growth is not the primary focus.
Penton gross cost savings expected to rise from ~$15m in 2017 to ~$22.5m in 2018; revenue initiatives include Market Maker expansion and SupplySide China launch in Guangzhou.
Proposed UBM combination anticipated to complete in Q2 2018, subject to shareholder approval and antitrust filings; integration planning was underway.
Latest events from Informa
- Global pharma events pair supply-chain reach with data-led growth opportunities.INF
Investor presentation - 9M revenue grew 6.5%; double-digit adjusted EPS growth guidance was reaffirmed.INF
Q3 2026 TU - Resilient subscriptions and cost actions anchor a £1.7bn FY21 transition-year baseline.INF
H2 2020 - Strong 2019 cash generation met COVID-19 disruption with ~£450m of events rescheduled.INF
H2 2019 - Revenue, cash and earnings grew as exhibitions and U.S. scale reshaped the portfolio.INF
H2 2016 - Underlying growth reached 3.7% as UBM integration advanced and synergies set up 2019.INF
H2 2018 - Strong cash generation and rising dividends funded a measured growth and portfolio reset.INF
H2 2014 - Record 26.4% operating margin, strong cash generation and lower debt marked FY2011.INF
H2 2011 - 10.1% five-month growth, a £0.5bn buyback and a Q4 2024 TechTarget target.INF
AGM 2024 & Trading update